Cargando…
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age
An inactivated poliovirus vaccine candidate using Sabin strains (sIPV) grown on the PER.C6® cell line was assessed in infants after demonstrated immunogenicity and safety in adults. The study recruited 300 infants who were randomized (1:1:1:1) to receive one of 3 dose levels of sIPV or a conventiona...
Autores principales: | Ong-Lim, Anna Lisa, Shukarev, Georgi, Trinidad-Aseron, Mitzi, Caparas-Yu, Delia, Greijer, Astrid, Duchene, Michel, Scheper, Gert, van Paassen, Vitalija, Le Gars, Mathieu, Cahill, Conor P., Schuitemaker, Hanneke, Douoguih, Macaya, Jacquet, Jeanne-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196784/ https://www.ncbi.nlm.nih.gov/pubmed/35344464 http://dx.doi.org/10.1080/21645515.2022.2044255 |
Ejemplares similares
-
Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults
por: Leroux-Roels, Isabel, et al.
Publicado: (2020) -
An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model
por: Bockstal, Viki, et al.
Publicado: (2018) -
Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015) -
The Sabin live poliovirus vaccination trials in the USSR, 1959.
por: Horstmann, D. M.
Publicado: (1991) -
Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine
por: Shin, Woo-Jin, et al.
Publicado: (2018)